Nuclear Radiology: Page 24

PET/MRI develops growing role in cervical cancer

By Wayne Forrest

PET/MRI can become an increasingly valuable modality for the early-stage diagnosis of cervical cancer, especially when the disease spreads to the parametrium, according to a study published on 17 July in the European Journal of Radiology.

July 21, 2019

PET makes progress in determining Alzheimer's risk

By Wayne Forrest

A Swedish-led group has developed a novel technique that uses florbetapir-PET scans for tracking beta-amyloid accumulation in adults to gauge the risk of progression to Alzheimer's disease. The investigators published their findings online on 17 July in JAMA Neurology.

July 21, 2019

Siemens offers white paper on PET/MRI

By AuntMinnieEurope.com staff writers

Siemens Healthineers is making available a white paper on the clinical adoption of and applications relevant to PET/MRI.

July 9, 2019

MILabs receives Isreali contract

By AuntMinnieEurope.com staff writers

Preclinical imaging developer MILabs has taken an order for its Vector PET/SPECT/CT from Tel Aviv University's new Translational Medicine Center.

July 8, 2019

Bruker acquires preclinical, molecular software provider

By AuntMinnieEurope.com staff writers

MRI developer Bruker has acquired preclinical and molecular imaging software firm PMOD Technologies. Details of the transaction were not disclosed.

July 7, 2019

Bracco gets set to acquire Blue Earth Diagnostics

By Wayne Forrest

Contrast manufacturer Bracco Imaging is moving ahead with its plan to acquire molecular imaging company Blue Earth Diagnostics for over 390 million euros, with an additional closing adjustment estimated at 22 million euros. The deal is likely to be completed in the autumn.

July 7, 2019

Germans use spectroscopy to cut beam-range uncertainty

By Marric Stephens

German scientists are convinced that measuring the energy of gamma rays emitted during helium-ion radiotherapy can provide real-time verification of the beam's range in the patient. They have shown how to define the size of the range error in particle therapy, allowing more precise treatments with greater sparing of healthy tissue.

July 4, 2019

Which imaging modality is best for ovarian cancer?

By Philip Ward

FDG-PET/CT is more accurate than contrast-enhanced CT for detecting primary ovarian cancer, but due to CT's wide availability, cost-effectiveness, and quick interpretation by junior radiologists, it is preferred on a daily basis, attendees learned at the recent World Congress on obstetrics and gynecology in London.

July 3, 2019

ANSTO workers exposed to radiation

By AuntMinnieEurope.com staff writers

Three employees from the Australian Nuclear Science and Technology Organisation (ANSTO) have been exposed to radiation at its nuclear medicine production facility in New South Wales, according to a 1 July report in the Mandarin.

July 2, 2019

German group secures top molecular award

By Wayne Forrest

Researchers from Heidelberg, Germany, have won this year's Image of the Year prize at the annual Society of Nuclear Medicine and Molecular Imaging meeting in Anaheim, California, U.S., for their radiotracer that can detect 28 different types of cancer.

June 26, 2019

European Diploma in Radiology: How it works

By Prof. Laura Oleaga Zufiría

The European Diploma in Radiology (EDiR) has become a benchmark for medical specialty examinations in Europe. But what do you actually need to know about the EDiR, how is it organized, and how can it boost your career? Prof. Laura Oleaga Zufiría explains.

June 20, 2019

ANSTO licensed to fully supply Mo-99

By AuntMinnieEurope.com staff writers

The Australian Nuclear Science and Technology Organisation (ANSTO) has received a license to begin full production of molybdenum-99 (Mo-99) at its new nuclear facility.

June 11, 2019

Previous Page

Page 24 of 90

Next Page